Tackle Testosterone Deficiency (Hypgonadism)

Let's tackle testosterone deficiency (TD)

The prevalence of hypogonadism was 38.7% in men aged ≥45 years presenting to primary care offices, with significantly higher rates in men with obesity and/or type 2 diabetes, regardless of age.^1,^2,³

The Tackle TD campaign has been developed to raise awareness of testosterone deficiency (TD) and aims to provide men who may have the condition with the information and resources they require to seek the help they need.

* The prevalence of hypogonadism was 38.7% in men aged ≥45 years presenting to primary care offices, with significantly higher rates in men with obesity and/or type 2 diabetes, regardless of age.^1,^2,³

What is TD?

It’s a hormonal change that AFFECTS MEN OF ANY AGE which results in a very low testosterone level...

More information

Do you have TD symptoms?

Find out if you may have symptoms of TD by completing our SYMPTOM CHECKER..

Check your symptoms

See if you should have your testosterone level checked

Check your symptoms*

Simply select the symptoms you have been experiencing and then click the 'submit' button to view your results.
Remember there are no right or wrong answers, this is only a guide to help you and your doctor or nurse.

References

Mulligan T, Frick MF, Zuraw QC, Stemhagen A, McWhirter C. Prevalence of hypogonadism in males aged at least 45 years: the HIM study. Int J Clin Pract. 2006;60(7):762-769. Return to content
Chandel A, Dhindsa S, Topiwala S, Chaudhuri A, Dandona P. Testosterone concentration in young patients with diabetes. Diabetes Care. 2008;31(10):2013-2017. Return to content
Dhindsa S, Ghanim H, Batra M, Dandona P. Hypogonadotropic Hypogonadism in Men With Diabesity. Diabetes Care. 2018;41(7):1516-1525. Return to content
Mulhall JP, Trost LW, Brannigan RE, et al. Evaluation and Management of Testosterone Deficiency: AUA Guideline. J Urol. 2018;200(2):423-432. Return to content
Bhasin S, Brito JP, Cunningham GR, et al. Testosterone Therapy in Men With Hypogonadism: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2018;103(5):1715-1744. Return to content
Hackett G, Kirby M, Edwards D, et al. British Society for Sexual Medicine Guidelines on Adult Testosterone Deficiency, With Statements for UK Practice. The journal of sexual medicine. 2017;14(12):1504-1523. Return to content
Dohle GR, Arver S, Bettocchi C, Jones TH, Kliesch S. 2018 European Association of Urology (EAU) Guidelines on Male Hypogonadism. Available at https://uroweb.org/guideline/ male-hypogonadism. Return to content
Snyder PJ, Bhasin S, Cunningham GR, et al. Effects of Testosterone Treatment in Older Men. N Engl J Med. 2016;374(7):611-624. Return to content
Wu FC, Tajar A, Beynon JM, et al. Identification of late-onset hypogonadism in middle-aged and elderly men. N Engl J Med. 2010;363(2):123-135. Return to content
Rosen RC, Seftel AD, Ruff DD, Muram D. A Pilot Study Using a Web Survey to Identify Characteristics That Influence Hypogonadal Men to Initiate testosterone therapy (TTh). American journal of men’s health. 2018;12(3):567-574. Return to content
Shortridge EF, Polzer P, Donga P, Wade RL. Symptom report and treatment experience of hypogonadal men with and without type 2 diabetes in a United States health plan. Int J Clin Pract. 2015;69(7):783-790. Return to content
Morley JE, Charlton E, Patrick P, et al. Validation of a screening questionnaire for androgen deficiency in aging males. Metabolism. 2000;49(9):1239-1242. Return to content

Let's Tackle Testosterone Deficiency (TD)